Clinical Evaluation of the Scopio Cell Morphology Technology

ConditionBlood Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope

Disqualifiers

Patients not affected by blood disorders

Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope

Trial population

Pazienti affetti da emopatie

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

  • Blood cells classification

    Diagnostic test

    Comparison of the classification of peripheral blood and bone marrow cells with optical microscope reading with pre-classification using Scopio technology (AI based)

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Optical microscope reading and automatic pre-classification

Comparison between optical microscope reading and automatic pre-classification (AI based)

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: